Guidelines from the Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients

Neurological Sciences

Volumn 34, Issue 12, 2013, Pages 2085-2093

  Filippi, Massimo ^a   Rocca, Maria A ^a   Bastianello, Stefano ^b   Comi, Giancarlo ^a   Gallo, Paolo ^c   Gallucci, Massimo ^d   Ghezzi, Angelo ^e   Marrosu, Maria Giovanna ^f   Minonzio, Giorgio ^e   Pantano, Patrizia ^g   Pozzilli, Carlo ^h   Tedeschi, Gioacchino ⁱ   Trojano, Maria ^j   Falini, Andrea ^a   De Stefano, Nicola ^k  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^d SAN SALVATORE HOSPITAL   (Italy)

^e Hospital of Gallarate   (Italy)

^f UNIVERSITY OF CAGLIARI   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ SECOND UNIVERSITY OF NAPLES   (Italy)

^j UNIVERSITY OF BARI   (Italy)

^k UNIVERSITY OF SIENA   (Italy)

more..

Author keywords

Clinically isolated syndromes; Diagnosis; Magnetic resonance imaging; Monitoring; Multiple sclerosis

Indexed keywords

BETA INTERFERON; GADOLINIUM; INTERLEUKIN 6; NATALIZUMAB;

CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE COURSE; HUMAN; MEDICAL EXAMINATION; MULTIPLE SCLEROSIS; NEUROIMAGING; NEUROLOGIST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT MONITORING; PRACTICE GUIDELINE; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REVIEW; STANDARDIZATION; TREATMENT RESPONSE;

BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 84890561132     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-013-1485-7     Document Type: Review

References (28)

1. Filippi M, Rocca MA (2011) MR imaging of multiple sclerosis. Radiology 259(3):659-681
2. Filippi M, Rocca MA, De Stefano N et al (2011) Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol 68(12):1514-1520
3. Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292-302
4. Charil A, Yousry TA, Rovaris M et al (2006) MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol 5(10):841-852
5. Miller DH, Weinshenker BG, Filippi M et al (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14(9):1157-1174
6. (1995) Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology 45(7):1277-1285
7. Comi G, Filippi M, Barkhof F et al (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357(9268):1576-1582
8. Comi G, Martinelli V, Rodegher M et al (2009) Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet 374(9700):1503-1511
9. Kappos L, Freedman MS, Polman CH et al (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 8(11):987-997
10. Filippi M, Rocca MA, Calabrese M et al (2010) Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology 75(22):1988-1994
11. Ormerod IE, Miller DH, McDonald WI et al (1987) The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain 110(Pt 6):1579-1616
12. Filippi M, Gawne-Cain ML, Gasperini C et al (1998) Effect of training and different measurement strategies on the reproducibility of brain MRI lesion load measurements in multiple sclerosis. Neurology 50(1):238-244
13. Barkhof F, Filippi M, van Waesberghe JH et al (1997) Improving interobserver variation in reporting gadolinium-enhanced MRI lesions in multiple sclerosis. Neurology 49(6):1682-1688
14. Lycklama G, Thompson A, Filippi M et al (2003) Spinal-cord MRI in multiple sclerosis. Lancet Neurol 2(9):555-562
15. McDonald WI, Compston A, Edan G et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121-127
16. Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58(6):840-846
17. Swanton JK, Rovira A, Tintore M et al (2007) MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 6(8):677-686
18. Barkhof F, Filippi M, Miller DH, Tofts P, Kappos L, Thompson AJ (1997) Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials. J Neurol 244(2):76-84
19. Filippi M, Horsfield MA, Ader HJ et al (1998) Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Ann Neurol 43(4):499-506
20. Vrenken H, Jenkinson M, Horsfield MA, et al. (2012). Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol
21. Rudick RA, Lee JC, Simon J, Ransohoff RM, Fisher E (2004) Defining interferon beta response status in multiple sclerosis patients. Ann Neurol 56(4):548-555
22. Tomassini V, Paolillo A, Russo P et al (2006) Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis. J Neurol 253(3):287-293
23. Rio J, Rovira A, Tintore M et al (2008) Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients. Mult Scler 14(4):479-484
24. Rio J, Castillo J, Rovira A et al (2009) Measures in the first year of therapy predict the response to interferon beta in MS. Mult Scler 15(7):848-853
25. Sormani M, Rio J, Tintore M et al (2013) Scoring treatment response in patients with relapsing multiple sclerosis. Mult Scler 19(5):605-612
26. Sormani M, Signori A, Stromillo M, De Stefano N (2013) Refining response to treatment as defined by the Modified Rio Score. Mult Scler
27. Freedman MS, Patry DG, Grand'Maison F, Myles ML, Paty DW, Selchen DH (2004) Treatment optimization in multiple sclerosis. Can J Neurol Sci 31(2):157-168
28. Freedman MS, Selchen D, Arnold DL et al (2013) Treatment optimization in MS: Canadian MS Working Group updated recommendations. Can J Neurol Sci 40(3):307-323